Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Optimizing beta-blocker use after myocardial infarction.

P A Howard¹, E F Ellerbeck

¹Department of Pharmacy, University of Kansas Medical Center, Kansas City 66160-7231, USA.

American Family Physician

|November 1, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hyperglycaemia and mortality of diabetic patients with candidaemia.

Diabetic medicine : a journal of the British Diabetic Association·2005

Same author

Fecal occult blood test use by Kansas medicare beneficiaries.

Preventive medicine·2001

Same author

Direct observation of counseling on colorectal cancer in rural primary care practices.

Journal of general internal medicine·2001

Same author

Direct observation of smoking cessation activities in primary care practice.

The Journal of family practice·2001

Same author

Quality in managed care: promise versus reality.

The American journal of medicine·2001

Same author

Warfarin for stroke prevention in octogenarians with atrial fibrillation.

The American journal of geriatric cardiology·2001

Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026

Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026

Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026

Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026

Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026

Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

See all related articles

Beta blockers significantly reduce mortality after myocardial infarction but are underutilized. Careful use of these drugs, even in elderly patients or those with diabetes or heart failure, offers substantial benefits that outweigh risks.

Area of Science:

Cardiology
Pharmacology

Background:

Beta-adrenergic blockers are proven to reduce mortality post-myocardial infarction.
Underutilization of beta blockers is observed, particularly in elderly patients and those with comorbidities like diabetes or heart failure.

Purpose of the Study:

To address the underprescription of beta blockers after myocardial infarction.
To highlight the benefits of beta blockers in specific patient populations often excluded from therapy.

Main Methods:

Review of existing studies on beta blocker efficacy and safety post-myocardial infarction.
Analysis of benefits versus risks in elderly patients and those with diabetes or heart failure.

Main Results:

Patients with advanced age, diabetes, or heart failure derive significant benefits from beta blockade.

Related Experiment Videos

Fear of adverse effects often leads to underutilization, despite evidence supporting their use.

Conclusions:

Beta-blocker therapy is indicated for most patients post-myocardial infarction, including the elderly and those with comorbidities.
Careful selection of cardioselective agents, appropriate dosing, and monitoring can mitigate risks, maximizing benefits.